Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

8.7%

2 terminated out of 23 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

44%

4 of 9 completed with results

Key Signals

4 with results82% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (11)
P 2 (2)
P 3 (1)
P 4 (2)

Trial Status

Completed9
Active Not Recruiting4
Withdrawn2
Enrolling By Invitation2
Terminated2
Recruiting2

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT02204228TerminatedPrimary

TITAN™ Reverse Shoulder System

NCT05049993Active Not RecruitingPrimary

Pyrocarbon Clinical Follow-up Study

NCT03409718Active Not RecruitingPrimary

Database Retrieval for the Comprehensive Shoulder

NCT03404778Enrolling By Invitation

Comprehensive Reverse Shoulder Data Collection

NCT03726554Not ApplicableActive Not Recruiting

Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty

NCT05160441Phase 3CompletedPrimary

Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis

NCT04634773Not ApplicableActive Not RecruitingPrimary

Unravelling the Etiology of Shoulder Osteoarthritis

NCT06897124CompletedPrimary

Patients Experiences of Rehabilitation Before and After Reverse Shoulder Arthroplasty

NCT04468178Not ApplicableRecruitingPrimary

Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless Anatomic Shoulder

NCT04228419Not ApplicableRecruitingPrimary

TSA vs RSA in Glenohumeral Osteoarthritis

NCT03806881Enrolling By Invitation

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant

NCT03382262Phase 2CompletedPrimary

Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip

NCT04160091Phase 2TerminatedPrimary

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

NCT03887650Phase 4Completed

LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs

NCT01539122Not ApplicableCompletedPrimary

Clinical Experience With the Zimmer Trabecular Metal (TM) Glenoid in Total Shoulder Arthroplasty

NCT03385408Not ApplicableCompletedPrimary

Effectiveness of HILT in Shoulder Osteoarthritis

NCT04134442Phase 4WithdrawnPrimary

Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome

NCT03770546Not ApplicableWithdrawnPrimary

Amnion-Based Injections in the Shoulder

NCT00479687Not ApplicableCompletedPrimary

SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder

NCT01697865Not ApplicableCompletedPrimary

Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction

Scroll to load more

Research Network

Activity Timeline